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ABSTRACT 
Objective: The present study was carried out to evaluate the potential pharmacological interactions in a group of adult 
hospitalized patients due to an epileptic crisis. 
Methodology: Descriptive-analytical study. Data was obtained from medical records of hospitalized patients during the 
investigation period.  
Results: 937 patients were enrolled in the study, 143 different drug interactions were detected in 35 patients, which involved 
46 medicines administered. The interactions were classified according to their theoretical relevance in serious (18.88%), 
significant (51.04%) and minor (30.07%). 48.57% of patients presented drug interactions with nutrients. 
Conclusion: The intervention of a multidisciplinary team is necessary for the management of these patients, which includes 
nutritionists specially trained in aspects of pharmacokinetics and pharmacodynamics, in order to minimize the incidence of 
pharmacological interactions. 
Keywords: Pharmacological interactions, Nutrients, Hospitalization 
International Journal of Surgery and 
Invasive Procedures 





Original Research Article: Open Access 
 
Pharmacological Interactions in Patients with Epileptic Crisis Hospitalized in 
a Public Institution 
Carolina Soledad Montiel1, María Ignacia Troche2, Lupe Marin3, Gladys Lugo de Ortellado1, Lourdes 
Samaniego1, Gustavo H Marin3* and Gladys Mabel Maidana1 
*1Faculty of Chemical Sciences. National University of Asuncion, Paraguay 
2National Center for Burns and Reconstructive Surgery, Paraguay  
3Department of Pharmacology, Faculty of Medicine, National University of La Plata, Argentina.  
 
Received December 12, 2019; Accepted December 26, 2019; Published January 28, 2020 
 
INTRODUCTION 
The term drug interactions (DI) refer to a clinical situation 
in which the action of a drug is altered by the presence of 
another drug or food, with neutral, beneficial or malefic 
consequences [1]. The risk of its occurrence and severity is 
due to factors related to the patient, the medicines 
themselves and the medical prescription [2]; they can end 
either in a therapeutic failure or in the appearance of adverse 
effects. There are some illnesses that due to their 
characteristics or type of medications used have a higher risk 
of interactions. This is the case of patients diagnosed with 
epilepsy. Epilepsy is one of the most common neurological 
diseases, with more than 50 million people affected around 
the world and of which about 80% come from developing 
regions. It is estimated that about 5 million people suffer 
from the disease in Latin America and the Caribbean 
countries [3]. Epilepsy is characterized by recurrent seizures, 
which are brief episodes of involuntary movements that can 
affect a part of the body (partial seizures) or its entirety 
(generalized seizures) and are some cases accompanied by 
loss of consciousness. Pharmacological treatment for 
epilepsy manages to control epileptic seizures in up to 70% 
 
of patients, some of them severe that need hospital 
admission [3]. 
The objective of this work is to identify the possible drug 
interactions in hospitalized patients due to epileptic seizures; 
in order to optimize their health care. 
MATERIALS AND METHODS 
Type of study 
Descriptive-analytical, retrospective study. 
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The present work was developed in a Public Hospital 
Specialized in Burns, located in the city of Asunción, 
Republic of Paraguay. 
Population 
Adult patients >18 years hospitalized for burn injuries for 
more than 48 h as a result of epileptic seizures, who entered 
the boarding school unit in the period from January 2015 to 
December 2017. 
Data collection instrument 
Review of medical records of hospitalized patients. 
Pharmaceutical records of dispense record. 
Instrument for identification and classification of 
interactions: Medscape Interaction Checker (WebMD, LLC). 
Variables 
Date of admission, date of discharge, age, sex, origin, 
number, type, dose of medicines dispensed and type of 
administration, type of food and nutritional supplements 
administered and type of intake. 
STATISTICAL ANALYSIS 
The statistical analysis was performed with the EPI INFO 
statistical software, each variable was coded for the 
programme management, with its description and its 
categories. This software allows expressing the results in 
frequency and percentage of each study variable. 
ETHICAL ASPECTS 
This work was carried out according to international 
standards for biomedical research in human beings proposed 
by the Council of International Organizations of Medical 
Sciences (CIOMS) where the confidentiality of data 
obtained from patient records is respected, for this; the 
project was presented to the Research Ethics Committee of 
the Faculty of Chemical Sciences, National University of 
Asuncion (UNA) Paraguay Republic and each patient was 
asked to sign an informed consent for this purpose. 
RESULTS 
A total of 937 adult patients entered the Burns boarding 
room unit during the study period, 35 patients of whom 
suffered burns due to epileptic seizures, which represent 
3.73% of all admissions. 62.86% of the patients belong to 
the female sex. The age range is between 18 to 74 years, 
with an average of 40 years and a standard deviation of 16.5. 
65.71% of patients come from rural areas (Table 1). 
 
 
Table 1. Characteristics of the patients included in the study. 
 
 Variables Frequency Percentage 
GENDER 
Male 13/35 37,14% 
Female 22/35 62,86% 
AGE (YEARS) 
18-34 12/35 34,29% 
35-59 18/35 51,43% 
60 or more 5/35 14,29% 
CITY 
Urban versus 
Rural 12/35 34,29% 






The administration of registered and dispensed 
medicines allowed us to identify that the patients 
enrolled in the study received between 5 and 28 
medications throughout the day of hospitalization (29 ± 





It was found that patients with ages over 60 years have a 
tendency to receive a greater quantity of medicines 
(Figure 2), which is directly related to the risk of 
possible pharmacological interactions in patients with 
that age range. 
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Of a total of 46 medicines that were detected in the 
interactions, the most prescribed correspond to group N 
(Drugs that act on the Nervous System) according to ATC.  
Phenytoin was the most prescribed and administered 
medicines, with a frequency of 71.43% of the total patients. 
Then they are followed by those of group J, anti-infective 
drugs for systemic use, in which ciprofloxacin 
corresponds to the most administered medicines within the 





Table 2. Classification of the most frequent medicines administered. 
 
Nervous system. Group N 
Medicine ATC n/N Percentage (N=35) 
Phenytoin N03AB05 25/35 71.43% 
Propofol N01AX10 16/35 45.71% 
Diazepam N01AX03 15/35 42.86% 
Clonazepam N03AE01 15/35 42.86% 
Carbamazepina N03AF01 12/35 34.29% 
Fentanyl N01AH01 11/35 31.43% 
Anti-infective in general for systemic use. Group J 
Ciprofloxacin J01MA02 16/35 45.71% 
CeftazidDIe J01DD02 13/35 37.14% 
Amikacine J01GB06 2/7 28.57% 
Digestive system and metabolism. Group A 
Ranitidine A02BA02 24/35 68.57% 
Omeprazole A02BC01 12/35 34.29% 
Skeletal Muscle System. Group M 
Ibuprofen M01AE01 19/35 54.28% 
Ketorolac M01AB15 16/35 45.71% 
Blood and hematopoietic. Group B 
Heparin B01AB01 14/35 40.00% 
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The patients included in this study presented a total of 143 
pharmacological interactions, which were classified 
according to their theoretical relevance in serious; which 
represent 18.88% of the interactions; 51.04% significant and 
30.07% lower (Figure 4). The lowest number of potential 
interactions presented by the patients was 4 and the highest 








1. IF severe. 2. IF significative. 3. IF minors. Expressed as a percentage of the 143 potential Ifs 
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Table 3. More frequent serious drug interactions. 
 

























One increases the effects of the other by pharmacodynamic 
synergism. Avoid or use alternative drugs. It can cause 





Cefazolin increases the effects of heparin by pharmaco 




Cefazolin increases the effects of enoxaparin by 













One drug increases the effects of the other by 
pharmacodynamic synergism. Avoid or use alternative drugs. 
It can cause respiratory depression, hypotension, deep 







Carbamazepine will decrease the level or effect of midazolam 
by affecting the metabolism of the liver/intestinal enzyme 
CYP3A4. Avoid or use alternative drugs. 









Phenytoin will decrease the level or effect of diazepam by 
affecting the metabolism of the liver/intestinal enzyme 









Phenytoin will decrease the level or effect of amikacin by the 
P-glycoprotein exit transporter (MDR1). Use 
caution/monitor. 
Phenytoin Heparin 12/143 8.39% 
Heparin increases phenytoin levels by an unknown 










Ciprofloxacin decreases the effects of phenytoin by an 
unknown mechanism. Use caution/monitor. Serum 
concentrations of phenytoin should be monitored in patients. 
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48.57% of the patients in the study had drug-nutrient 
type interactions (Table 6), corresponding to 3.50% 
of the total drug interactions. The most frequent 
potential interaction was that of Phenytoin with 
Calcium (8.39%). 
  




































El Omeprazole aumentará el nivel o efecto de la phenytoin al 










Omeprazolee increases the level or effect of phenytoin by 










Modify therapy/monitor closely. Mechanism: unknown. 
Increased risk of central nervous system stimulation and 
seizures with high doses of fluoroquinolones. 
Medicine 1 Medicine 2 n/N Percentage (N=110) Potencial DAR 
Phenytoin Ranitidine 17/143 11.89% 
Ranitidine increases phenytoin levels by decreasing 
metabolism. 
Phenytoin Ibuprofen 7/143 4.89% Phenytoin increases the level or effect of ibuprofen. 
Phenytoin Atracurio 5/143 3.50% 










Phenytoin decreases paracetamol levels by increasing 
metabolism. Increased levels of metabolites of hepatotoxic 
metabolites 
Omeprazole Diazepam 6/143 4.20% 
Omeprazolee will increase the level or effect of diazepam by 
affecting liver enzyme metabolism CYP2C19. 
Atracurio Clonazepam 6/143 4.20% Clonazepam decreases the effects of atracurium by 
pharmacodynamic antagonism 
Medicine Nutrient n/N Percentage Potencial DAR 
Phenytoin Calcio 12/110 10.91% Pueden aumentar las necesidades de Calcio 
Omeprazole Calcio 8/110 7.27% Se produce déficit de Calcio 
Paracetamol Calcio 4/110 3.63% Se produce déficit de Calcio 
Furosemida Calcio 2/110 1.81% Se produce déficit de Calcio 
Phenytoin Ácido fólico 1/110 0.91% Puede reducir la concentración plasmática de phenytoin 
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The prevalence of interactions observed in the 
present study was directly proportional to the 
increase in the age of the patients, suggesting that 
older patients are more vulnerable due of their 
greater number of prescribed drugs, the complexity 
in treatment and a reduction in renal function [2,4]. 
Pharmacological interactions themselves are a 
cause of hospital admission, but in practice this is 
relatively unusual. In daily practice only some of 
them have relevant clinical consequences that 
warrant hospitalization. Although it is very difficult 
to know the real frequency and clinical relevance of 
the interactions, it is currently known that many of 
them do not pose a risk to the patient and those that 
are clinically significant only occur in a small 
proportion of patients. 
In this study 143 interactions in 937 patients were 
detected, which are significantly smaller than the 
data provided from other published studies. Several 
authors found 329 theoretical interactions in 412 
patients, although it should be noted that these data 
cannot be directly compared with our study, due to 
the methodological differences, population and 
design, which contributes considerably for the 
variation of the observed frequencies [4]. 
The interactions found in our work were classified 
into 3 levels: serious, significant and minor; the 
“significant” ones were the most prevalent 
(51.04%), a fact that matches with other 
observations made by various authors [2]. 
Co-morbidities and the amount of drugs co-
administered can increase the incidence of drug-
related adverse effects and therefore, increase the 
risk of injury. For example, drowsiness is a 
common side effect of antiepileptic drugs and could 
be enhanced due to their association with hypnotic 
drugs or with psychiatric problems [5]. 
Regarding the number of medicines administered 
and their indication, it was observed that there was a 
higher frequency of medicines with action on the 
nervous system, being phenytoin (anti-epileptic) 
the most administered drug (54.34%) and therefore 
the medicine most involved in possible interactions. 
In addition, carbamazepine and clonazepam, also 
used to control epileptic seizures, were found 
within the group.  
Some of the anti-epileptics bind extensively to 
plasma proteins. Only the unbound (free) fraction of 
the drug is able to pass through membranes and 
have pharmacological activity, hence many drug-
drug interactions may occur as a result of 
competition for protein binding sites as observed in 
the case of phenytoin-ibuprofen or phenytoin-
diazepam in our results. 
From these data it is inferred that it might be 
appropriate to monitor the levels of the free 
fraction of drugs only in those cases where drug 
interactions are important and have sufficient risk 
to the health of patients [6]. 
Although monitoring would not be useful in all 
cases, it should be performed for drugs with the 
greatest potential to produce interactions: those 
with a narrow therapeutic index, which require 
precise control of plasma concentrations, those 
with dose-response curves with a broad slope, 
saturable metabolism or in case there is an 
indication of chronic treatment [7]. 
In the second place in the ranking of the 
interactions, we identified drugs from therapeutic 
group called “anti-infective for systemic use” 
(Group J), in 34.78% interaction of the cases, being 
ciprofloxacin the most prevalent in the group. 
Microbial use was associated with age, co-
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morbidities and toxic habits such as smoking and 
alcoholism of patients [8]. 
It was detected that 48.57% of the patients under 
study presented an interaction of the drug-nutrient 
type. The most frequent case of this type was that 
phenytoin with calcium (8.39%), an essential 
component of nutritional supplements. This fact is 
clinically relevant, since anticonvulsants have a 
higher risk of producing bone demineralization and 
fracture on pathological bone, events that are 
facilitated by risk factors such as vitamin D 
deficiency and hypocalcaemia [9]. 
To assess the safety of concomitant use of drugs, 
the different characteristics of the interaction must 
be studied. 
In this context, the presence of the clinical 
pharmacist in each of the hospital units is essential 
to be able to monitor the pharmacotherapeutic 
treatment and taking into account other variables 
inherent to the patient, which go unnoticed by 
other disciplines and professions; in order to 




The present study 48.57% of hospitalized patients 
with epilepsy, a drug-nutrient or drug interactions 
were detected. The drugs involved belong 
predominantly to the group acting on the nervous 
system, being phenytoin the medicine that presented 
the greatest interaction risk.  
The presence of a clinical pharmacist could help to 
prevent and reduce the incidence of drug 
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